Zhengmao Ye

Title: Innovations of Zhengmao Ye in T Cell and B Cell Modulation

Introduction

Zhengmao Ye is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of immunology, particularly in the modulation of T cell and B cell activation. With a total of 2 patents, his work has the potential to impact therapeutic strategies for various immune-related conditions.

Latest Patents

Zhengmao Ye's latest patents focus on methods and compositions for modulating T cell and/or B cell activation. The first patent provides methods for reducing or enhancing T cell activation and/or B cell activation in a subject. This is achieved by administering an effective amount of an inhibitor or enhancer of Semaphorin 6D (Sema6D) activity on T cells and/or B cells. The second patent mirrors this innovation, emphasizing the importance of Sema6D in immune response modulation.

Career Highlights

Zhengmao Ye is affiliated with the University of North Carolina at Chapel Hill, where he conducts his research. His work is characterized by a commitment to advancing our understanding of immune system dynamics and developing novel therapeutic approaches.

Collaborations

Zhengmao Ye collaborates with notable colleagues, including Jenny P-y Ting and Brian P O'Connor. These partnerships enhance the depth and breadth of his research, fostering innovation in the field.

Conclusion

Zhengmao Ye's contributions to the modulation of T cell and B cell activation represent a significant advancement in immunology. His innovative patents and collaborative efforts continue to pave the way for future research and therapeutic developments.